London, United Kingdom
Xperiome, founded in 2015 and headquartered in the United Kingdom, is a global healthtech company innovating in the intersection of Health Care and Social Media. The company's slogan, "Get to know rare disease patients," encapsulates its mission to provide pharma companies with deep insights into the patient experiences of those suffering from rare diseases.
At the core of Xperiome's offerings is Raremark, a multifaceted platform that supports rare disease patients throughout their health journey. It serves as a community for sharing insights, a comprehensive library of lived experiences, and a sophisticated matching engine that connects patients to research opportunities. This approach facilitates faster and smarter research matching, leveraging a rich data-driven knowledge bank.
In its most recent funding round, Xperiome secured a £3.00M Series A investment on 22 October 2018. Notable investors included Ananda Impact Ventures, Oltre Venture, Albion VC, Cass Entrepreneurship Fund, and SyndicateRoom, underscoring the company's appeal in the investment landscape.
